Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

WATERS CORPORATION

Waters Corp. designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performan... read more Featured Products: More products

Download Mobile App




Blood Test Potentially Predicts Alzheimer’s Disease

By LabMedica International staff writers
Posted on 03 Jun 2014
A blood test has the potential to predict Alzheimer’s disease before patients start showing symptoms and it could be the key to curing this devastating illness.

Current biomarkers for Alzheimer’s disease (AD) are limited because they are time consuming, invasive or expensive and while blood-based biomarkers may be a more attractive option, none can currently detect preclinical AD with the required sensitivity and specificity.

Scientists at Georgetown University Medical Center (Washington DC, USA) enrolled cognitively healthy adults age 70 years and older, in a five year observational study. More...
Over the course of the study, 74 participants met criteria for amnestic mild cognitive impairment (aMCI) or mild Alzheimer's disease (AD). Blood samples were taken from selected participants.

To measure the biomarkers the team used liquid chromatography–mass spectrometry methods using an Acquity H-class Ultra Performance Liquid Chromatography (UPLC) system and mass spectrometry was performed on a quadrupole time-of-flight (Q-TOF) instrument, the Xevo G2 QTOF (Waters Corporation, Milford, MA, USA). Targeted metabolomic analysis of plasma samples was performed using the Absolute-IDQ P180 kit (BIOCRATES; Innsbruck, Austria).

The investigators discovered and validated a set of ten lipids from peripheral blood that predicted phenoconversion to either amnestic mild cognitive impairment or Alzheimer's disease within a two to three year timeframe with over 90% accuracy. This biomarker panel, reflecting cell membrane integrity, may be sensitive to early neurodegeneration of preclinical Alzheimer's disease.

Janet B. Kreizman, BA, the CEO of the American Association for Clinical Chemistry (AACC), said, “This discovery is a potentially enormous breakthrough in the fight against Alzheimer's. If research aimed at a cure for Alzheimer's is to move forward, it is crucial that Alzheimer's clinical trials find a way to recruit patients who are still asymptomatic, since they are the ones most likely to respond to treatment.” The expanded study will be presented at the upcoming AACC Annual Meeting & Clinical Lab Expo, which will be held July 27–31, 2014 in Chicago (IL, USA).

Related Links:

Georgetown University Medical Center 
Waters Corporation 
BIOCRATES



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Hematology Consumables
Bioblood Devices
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

Genetic Testing Identifies Inherited Predisposition in Children With Acute Leukemia

Childhood acute leukemia can involve inherited cancer predisposition that is not always apparent at diagnosis. Previous studies estimate that 4% to 10% of children with hematological malignancies carry... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.